
Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes

BodyCap receives medical CE mark for ingestible connected device e-Celsius

Minoryx Therapeutics receives Orphan Drug Designation from the US FDA

Three Novasep custom manufacturing sites renew FDA approval in 2016

Minoryx Therapeutics receives European Orphan Drug Designation for its lead candidate MIN-102

Provepharm’s Proveblue® Methylene Blue achieves full compliance with the latest US and EU pharmacopoeial standards
